Oncology PracticeGemtuzumab Extends Survival in Acute Myeloid LeukemiaDecember 12, 2011Leukemia, Myelodysplasia, Transplantation
Oncology PracticeStudy Characterizes Spectrum of Somatic Mutations in Chronic Lymphocytic LeukemiaDecember 12, 2011Leukemia, Myelodysplasia, Transplantation
Oncology PracticeStem Cell Transplant: Physical, Mental Health Burdens PersistDecember 11, 2011Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticePBSC Transplants from Unrelated Donors Show No Survival Advantage December 11, 2011Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeFDA Approves Chemotherapeutic Enzyme L-Asparaginase November 22, 2011Leukemia, Myelodysplasia, Transplantation
Oncology PracticeJAK Inhibitor Ruxolitinib Wins First FDA Approval in MyelofibrosisNovember 17, 2011Leukemia, Myelodysplasia, Transplantation
Oncology PracticeGeriatric Assessment Predicts Overall Survival in AMLNovember 11, 2011Leukemia, Myelodysplasia, Transplantation
Oncology PracticeMaking Inroads in Treatment of Adult ALLNovember 1, 2011Leukemia, Myelodysplasia, Transplantation
Oncology PracticeTransplant Protocol Benefits Elderly With Hematologic CancersNovember 1, 2011Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeRefined Risk Stratification Guides Leukemia Transplant DecisionsOctober 25, 2011Leukemia, Myelodysplasia, Transplantation
Oncology PracticeAmbulatory Encounters for Hematology/Oncology Unchanged Since 2007October 13, 2011Leukemia, Myelodysplasia, Transplantation
Oncology PracticeFDA: Increased PAH Risk Seen With Dasatinib October 11, 2011Leukemia, Myelodysplasia, Transplantation
The Journal of Community and Supportive OncologyPersonalized medicine: myth to realitySeptember 1, 2011Lung CancerMelanomaLeukemia, Myelodysplasia, Transplantation
Hematology TimesCD19-redirected T cells induce remission in CLL patientsAugust 10, 2011Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesBrd4: Potential new target in AMLAugust 4, 2011Leukemia, Myelodysplasia, TransplantationAML
